Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Helicobacter Infections

• A Phase 1, Multiple Oral Administrations of TNP-2092 Capsules in Asymptomatic Healthy People With Helicobacter Pylori Infection
• Bismuth Quadruple Therapy Versus Standard Triple Therapy
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection
• Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants
• A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules
• Levofloxacin Concomitant Versus Levofloxacin Sequential
• Rescue Therapy for Helicobacter Pylori Infection
• Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）
• Eradication of H. Pylori Infection With Moxifloxacin
• Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
• Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection
• Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy
• Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial
• Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
• Effect of Probiotics on Eradication of Persistent H.Pylori Infection
• A RCT of the Efficacy of Tegoprazan 50mg QD in the Treatment of Helicobacter Pylori Infection ( TATH-1 )
• Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection Management
• A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection
• Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine
• The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial
• Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication Therapy
• 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection
• Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection
• Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
• Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection
• Helicobacter Pylori Eradication Therapy for Epileptic Children
• Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
• Influencing Factors of Helicobacter Pylori Infection and Eradication Failure
• Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
• Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
• Tetracycline Versus Doxycycline for HP Rescue Therapy
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
• Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment
• Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
• Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
• Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease
• Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia
• Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
• Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
• Tailored Juice-guided Eradication Therapy
• Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt
• High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment
• Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
• ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
• Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication
• A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis
• Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
• Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets
• Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin Solution
• Dexlansoprazole MR-Based Concomitant Quadruple Therapy
• Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication
• Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection
• Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies
• THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
• Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
• Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication
• Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy
• Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
• Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in Korea
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
• A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
• Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
• Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
• Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
• High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment
• Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
• Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection
• Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection
• Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection
• Triple Therapy With Tegoprazan in H. Pylori Positive Patients
• A Unique Regimen for Treatment of Helicobacter Pylori Infection
• Tailored Therapy for Clarithromycin-Resistant H. Pylori
• Tailored Therapy for Helicobacter Pylori Rescue Treatment
• High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
• Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
• A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children
• Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy
• A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
• Bismuth Based Quadruple Therapy 10 Days in Children
• The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori
• Sequential Versus Quadruple Therapy in the Second-line Treatment
• ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
• The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children
• Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study
• 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication
• Intraluminal Therapy for Helicobacter Pylori Infection
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
• Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
• Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment
• Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection
• 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
• Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment
• Intragastric pH and Bismuth Effect for H. Pylori Eradication
• Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
• Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection
• Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori
• Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
• Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment
• Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
• Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy
• Tailored Therapy for Helicobacter Pylori in Children
• Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication
• Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
• High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
• Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole
• Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy
• Personalized Treatment for Refractory H Pylori Infection
• Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
• Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication
• Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
• Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients
• Helicobacter Pylori and Proton Pump Inhibitor
• Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
• Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
• Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens
• The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
• Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
• The Diagnostic Validity of the Urea Breath Test
• Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
• The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
• Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
• The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
• Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
• High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection
• Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
• Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
• Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
• Helicobacter Pylori Eradication Study in Parkinson's Disease
• Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
• Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
• An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection
• ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
• CANHelp Working Group Treatment Trials
• Anti-H. Pylori Effect of Deep See Water
• Eradication Rates of Helicobacter Pylori and Its Affecting Factors
• Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
• 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea
• Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection
• Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy
• Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
• Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication
• Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
• Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
• Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection
• Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients
• Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori
• Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori
• Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
• 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
• New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study
• 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication
• Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
• Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
• Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
• A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection
• Molecular Detection of Antibiotic Resistance and H Pylori Eradication
• Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
• Helicobacter Pylori Eradication to Prevent Gastric Cancer
• Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication
• Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori
• Sequential and Hybrid Therapies for H Pylori Infection
• S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
• Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia
• Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot Study
• The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study
• Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries
• Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection
• Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
• 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
• Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication
• Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms
• Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
• Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
• Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori
• Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy
• Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
• Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
• First Time in Man Study of Finafloxacin Hydrochloride
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
• Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
• Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled Trial
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
• The Effect of H. Pylori Infection on Iron Metabolism
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
• Breath Ammonia Method for H. Pylori Detection: Phase II
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships
• Community-based Helicobacter Pylori Eradication
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
• Helicobacter Pylori Eradication With a New Sequential Treatment